Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phase Two”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06358950
What this trial is testing

Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 92
Testing effectiveness (Phase 2)Study completedNCT05578391
What this trial is testing

Passive Immunotherapy In Patients With SARS CoV-2

Who this might be right for
COVID-19
Fundacin Biomedica Galicia Sur 61
Testing effectiveness (Phase 2)Study completedNCT00417391
What this trial is testing

Phase II Study of RR110 in Patients With Active Crohn's Disease

Who this might be right for
Crohn's Disease
R&R Inc. 24
Testing effectiveness (Phase 2)Study completedNCT01309997
What this trial is testing

Imatinib and Rituximab in Treating Cutaneous Sclerosis in Patients With Chronic Graft-Versus-Host Disease

Who this might be right for
Graft Versus Host DiseaseSystemic Scleroderma
Lee, Stephanie 72
Testing effectiveness (Phase 2)Study completedNCT04997382
What this trial is testing

Chemotherapy Combined with ICIs in First-line Alectinib Failed Patients with ALK-rearranged NSCLC

Who this might be right for
Non-small Cell Lung Cancer
Hunan Province Tumor Hospital 112
Large-scale testing (Phase 3)Study completedNCT00605280
What this trial is testing

A Multi-Center Trial To Evaluate The Safety And Efficacy Of Pegaptanib Sodium(Macugen) Injected Into The Eye Every 6 Weeks For Up To 2 Years For Macular Swelling Associated With Diabetes, With An Open-Label Macugen Year Extension.

Who this might be right for
Macular Edema Associated With Diabetes Mellitus
Pfizer 317
Testing effectiveness (Phase 2)Study completedNCT04632459
What this trial is testing

Pembrolizumab Plus Ramucirumab in Metastatic Gastric Cancer

Who this might be right for
Gastric Cancer
Samsung Medical Center 26
Testing effectiveness (Phase 2)Study completedNCT04758780
What this trial is testing

Imaging Performance Assessment of 89Zi-girentuximab (89Zr-TLX250) PET in Metastatic Triple Negative Breast Cancer

Who this might be right for
Triple Negative Breast Cancer
Institut Cancerologie de l'Ouest 12
Not applicableUnknownNCT03936179
What this trial is testing

High Dose PET/CT-guided Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer

Who this might be right for
Esophageal Cancer
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 50
Testing effectiveness (Phase 2)WithdrawnNCT03862079
What this trial is testing

Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics

Who this might be right for
Graft-versus-host Disease Prevention
M.D. Anderson Cancer Center
Not applicableUnknownNCT02848196
What this trial is testing

An Image-guided SBRT for Adrenal Gland Metastasis in Oligometastatic Patients

Who this might be right for
Adrenal Gland Metastases
Istituto Clinico Humanitas 40
Testing effectiveness (Phase 2)Study completedNCT00483496
What this trial is testing

Evaluation of the Protection Activity of Microfine Titanium Dioxide (Ti02), Pigmentary Ti02 and Bisoctrizole and Their Combinations in Voluntary Patients With Idiopathic Solar Urticaria (SU)

Who this might be right for
Idiopathic Solar Urticaria
Orfagen 16
Testing effectiveness (Phase 2)Study completedNCT01245426
What this trial is testing

A Study in Asthmatics to Determine the Efficacy and Dose Response of Repeat Doses of GW870086X on Forced Expiratory Volume in 1 Second (FEV1)

Who this might be right for
Asthma
GlaxoSmithKline 136
Testing effectiveness (Phase 2)UnknownNCT03693326
What this trial is testing

PDR001 in Patients With Non-small Cell Lung Cancer Harboring KRAS/NRAS Mutation or no Actionable Genetic Abnormalities

Who this might be right for
CancerLung Cancer MetastaticImmunotherapy
Asan Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT00822315
What this trial is testing

Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis

Who this might be right for
HIV InfectionsTuberculosis
ANRS, Emerging Infectious Diseases 155
Large-scale testing (Phase 3)Study completedNCT02766335
What this trial is testing

Lung-MAP: Durvalumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers

Who this might be right for
Recurrent Squamous Cell Lung CarcinomaStage IV Squamous Cell Lung Carcinoma AJCC v7
SWOG Cancer Research Network 116
Testing effectiveness (Phase 2)Active Not RecruitingNCT06106308
What this trial is testing

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

Who this might be right for
Metastatic Colorectal CancerCRCKRAS/NRAS Mutation
Cardiff Oncology 110
Testing effectiveness (Phase 2)Study completedNCT01380808
What this trial is testing

Capecitabine and Pseudomonas Aeruginosa Combination in Metastatic Breast Cancer (MBC)

Who this might be right for
Metastatic Breast Cancer
Fudan University 100
Not applicableUnknownNCT02480517
What this trial is testing

Sham Controlled Study of Renal Denervation for Untreated Stage I and II Hypertension

Who this might be right for
Hypertension
Kona Medical Inc. 60
Testing effectiveness (Phase 2)Study completedNCT02125318
What this trial is testing

Anagrelide Controlled Release (GALE-401) in Patients With High Platelet Counts Due to Bone Marrow Disorders

Who this might be right for
ThrombocytosisMyeloproliferative Neoplasms
Galena Biopharma, Inc. 18
Next Page